Paronychia arabica
Paronychia arabica · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Paronychia arabica is a medicinal plant that has garnered scientific interest due to its diverse phytochemical profile. Research indicates that the plant contains bioactive compounds, specifically lignans, which contribute to its therapeutic potential. Studies have focused on the extract of the aerial parts to evaluate its biological efficacy against various pathogens. Notably, investigations have explored its impact under conditions related to SARS-CoV-2 to determine its antiviral capabilities. This plant thus represents a significant subject in the search for natural agents to combat emerging viral threats.
- Synonyms
- Illecebrum Arabicum
- Common names
- Not available
- Family
- Caryophyllaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Paronychia arabica is a distinctive plant known by several different names across various linguistic traditions. In Russian-speaking regions, it is commonly referred to as Приноготовник аравийский. Moving to Hebrew, the species is identified by the name אלמוות ערבי. The plant also carries the Arabic designation داحسية عربية, reflecting its cultural presence in the Middle East. These diverse names highlight the wide geographical reach and botanical significance of this unique species.
Sources: Catalogue of Life (COL)
Synonyms
Paronychia arabica is a distinct botanical species often identified by its unique morphological characteristics. Within taxonomic literature, this plant is also recognized by the synonym Illecebrum arabicum. Such nomenclatural variations can sometimes cause confusion for researchers navigating diverse botanical databases. However, understanding these synonymous relationships is essential for maintaining accurate scientific records. Ultimately, recognizing both names ensures that the species is correctly identified across different studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Paronychia arabica is a distinctive species belonging to the vast kingdom Plantae. Within this diverse group, it is classified under the class Equisetopsida. This plant is further organized into the order Caryophyllales, which defines many of its biological characteristics. It holds a specific place within the family Caryophyllaceae, a group known for its unique floral structures. Ultimately, it is identified by its scientific genus, Paronychia, which helps botanists categorize its evolutionary lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Caryophyllaceae |
| Genus | Paronychia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Paronychia arabica is a resilient plant species with a broad geographical presence across Africa and Macaronesia, including the Canary Islands. Its range extends deeply into the continent, specifically throughout Northeast Tropical Africa and into Chad. Within the northern reaches of the continent, the species is well-established across the diverse landscapes of Algeria. It also maintains a significant presence in the arid regions of Egypt and Libya. This wide distribution highlights the plant's ability to adapt to various environments across the African landmass.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Paronychia arabica is characterized by its distinct herb growth form. As a self-supporting plant, it maintains its structure independently within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Paronychia arabica contains unique chemical compounds, including oxetane-containing lignans and a new megastigmane, that show potential as SARS-CoV-2 inhibitors. Molecular docking studies revealed that the compound paronychiarabicastigmane A exhibits a promising binding score against the SARS-CoV-2 main protease. This specific megastigmane achieves this inhibition by forming seven hydrogen bonds within the protease's active site. Furthermore, reactome pathway analysis suggests that the treatment targets GSK3 and GSK3B genes to inhibit viral replication. These findings highlight the plant's capacity to provide novel therapeutic targets for treating SARS-CoV-2 infection.
Preparations
Paronychia arabica is prepared as an extract of the aerial parts to facilitate chemical characterization. This specific preparation process allowed researchers to isolate several significant compounds, including two oxetane-containing lignans. Through this extraction, a new megastigmane known as paronychiarabicastigmane A was also identified. The resulting chemical profile from these aerial parts provides a foundation for studying prospective SARS-CoV-2 inhibitors. Ultimately, the use of this plant extract enables the exploration of molecular docking and potential therapeutic pathways.